Cemsidomide in Combination With Elranatamab

A Phase 1B, Open-label, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

  • 202885

Sorting 16 by

Dartmouth-Hitchcock Medical Center
Norris Cotton Cancer Center
Lebanon, NH
  • Not yet accepting
University of Nebraska Medical Center
Fred & Pamela Buffett Cancer Center
Omaha, NE
  • Not yet accepting
Norton Cancer Institute (St. Matthews)
St. Matthews Campus
Louisville, KY
  • Not yet accepting
START Midwest
Midwest
Grand Rapids, MI
  • Accepting patients
UCLA Medical Center, Santa Monica
UCLA Health
Santa Monica, CA
  • Not yet accepting
Huntsman Cancer Institute
University of Utah
Salt Lake City, UT
  • Not yet accepting
MD Anderson Cancer Center
The University of Texas
Houston, TX
  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 864-8426

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.